|
Structural Characterization of N‐Linked Glycans in the Receptor Binding Domain of the SARS‐CoV‐2 Spike Protein and their Interactions with Human Lectins
|
journal
|
October 2020 |
|
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV
|
journal
|
February 2020 |
|
Evolutionary dynamics of SARS‐CoV‐2 nucleocapsid protein and its consequences
|
journal
|
November 2020 |
|
HumanSARS CoV‐2 spike protein mutations
|
journal
|
January 2021 |
|
The epidemiology and clinical information about COVID-19
|
journal
|
April 2020 |
|
A naturally occurring deaminated neuraminic acid, 3-deoxy-D-glycero-D-galacto-nonulosonic acid (KDN). Its unique occurrence at the nonreducing ends of oligosialyl chains in polysialoglycoprotein of rainbow trout eggs.
|
journal
|
September 1986 |
|
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions
|
journal
|
September 2020 |
|
Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism
|
journal
|
October 2020 |
|
Exploitation of glycosylation in enveloped virus pathobiology
|
journal
|
October 2019 |
|
Biochemical characterization of SARS-CoV-2 nucleocapsid protein
|
journal
|
June 2020 |
|
Dual ELISA using SARS-CoV-2 nucleocapsid protein produced in E. coli and CHO cells reveals epitope masking by N-glycosylation
|
journal
|
January 2021 |
|
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
|
journal
|
April 2020 |
|
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
|
journal
|
September 2020 |
|
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
|
journal
|
November 2020 |
|
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
|
journal
|
December 2020 |
|
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
|
journal
|
April 2015 |
|
How glycobiology can help us treat and beat the COVID-19 pandemic
|
journal
|
January 2021 |
|
Virus–Receptor Interactions: The Key to Cellular Invasion
|
journal
|
August 2018 |
|
Binding of the SARS-CoV-2 spike protein to glycans
|
journal
|
June 2021 |
|
Structure and function of SemiSWEET and SWEET sugar transporters
|
journal
|
August 2015 |
|
Effects of Sialic Acid Modifications on Virus Binding and Infection
|
journal
|
December 2016 |
|
Glycosylation, ligand binding sites and antigenic variations between membrane glycoprotein of COVID-19 and related coronaviruses
|
journal
|
January 2021 |
|
Structural Analysis of Heparin-Derived 3- O -Sulfated Tetrasaccharides: Antithrombin Binding Site Variants
|
journal
|
April 2017 |
|
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry
|
journal
|
June 2021 |
|
N- and O-Glycosylation of the SARS-CoV-2 Spike Protein
|
journal
|
January 2021 |
|
Mass-Spectrometric Detection of SARS-CoV-2 Virus in Scrapings of the Epithelium of the Nasopharynx of Infected Patients via Nucleocapsid N Protein
|
journal
|
August 2020 |
|
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
|
journal
|
September 2020 |
|
Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV-2 Viral Spike
|
journal
|
March 2021 |
|
Solution conformations of N-linked oligosaccharides
|
journal
|
October 1987 |
|
What it will take to vaccinate the world against COVID-19
|
journal
|
March 2021 |
|
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
|
journal
|
November 2003 |
|
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
|
journal
|
April 2017 |
|
Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori
|
journal
|
August 2009 |
|
Protein-glycan interactions in the control of innate and adaptive immune responses
|
journal
|
May 2008 |
|
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets
|
journal
|
April 2014 |
|
Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy
|
journal
|
September 2016 |
|
Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro
|
journal
|
July 2020 |
|
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
|
journal
|
May 2020 |
|
AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells
|
journal
|
January 2021 |
|
SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response
|
journal
|
October 2020 |
|
Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
|
journal
|
May 2020 |
|
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
|
journal
|
February 2020 |
|
A pneumonia outbreak associated with a new coronavirus of probable bat origin
|
journal
|
February 2020 |
|
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|
journal
|
May 2020 |
|
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
|
journal
|
May 2020 |
|
Structural basis for human coronavirus attachment to sialic acid receptors
|
journal
|
June 2019 |
|
Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition
|
journal
|
September 2020 |
|
Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
|
journal
|
April 2021 |
|
Heparin and heparan sulfate: structure and function
|
journal
|
March 2002 |
|
Investigating changes in the gas-phase conformation of Antithrombin III upon binding of Arixtra using traveling wave ion mobility spectrometry (TWIMS)
|
journal
|
January 2015 |
|
Heparin and heparan sulfate: structure and function
|
journal
|
March 2002 |
|
Investigating changes in the gas-phase conformation of Antithrombin III upon binding of Arixtra using traveling wave ion mobility spectrometry (TWIMS)
|
journal
|
January 2015 |
|
α-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19
|
journal
|
June 2020 |
|
Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis
|
journal
|
February 2006 |
|
Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry
|
journal
|
May 2005 |
|
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
|
journal
|
November 2017 |
|
Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein
|
journal
|
September 2017 |
|
Human coronaviruses OC43 and HKU1 bind to 9- O -acetylated sialic acids via a conserved receptor-binding site in spike protein domain A
|
journal
|
January 2019 |
|
A Human Homolog of Angiotensin-converting Enzyme
|
journal
|
October 2000 |
|
Partial Enzymatic Deglycosylation Preserves the Structure of Cleaved Recombinant HIV-1 Envelope Glycoprotein Trimers
|
journal
|
May 2012 |
|
Glycosylation of the viral attachment protein of avian coronavirus is essential for host cell and receptor binding
|
journal
|
May 2019 |
|
The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles
|
journal
|
January 2021 |
|
Developments in Mass Spectrometry for Glycosaminoglycan Analysis: A Review
|
journal
|
January 2021 |
|
Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins
|
journal
|
January 2021 |
|
Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2
|
journal
|
May 2020 |
|
Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics
|
journal
|
June 2020 |
|
Site-specific characterization of SARS-CoV-2 spike glycoprotein receptor-binding domain
|
journal
|
September 2020 |
|
Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2
|
journal
|
October 2020 |
|
A proposed role for the SARS‐CoV‐2 nucleocapsid protein in the formation and regulation of biomolecular condensates
|
journal
|
June 2020 |
|
SARS-CoV-2 envelope protein topology in eukaryotic membranes
|
journal
|
September 2020 |
|
Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus
|
journal
|
March 2006 |
|
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|
journal
|
February 2020 |
|
Site-specific glycan analysis of the SARS-CoV-2 spike
|
journal
|
May 2020 |
|
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
|
journal
|
August 2020 |
|
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
|
journal
|
June 2020 |
|
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
|
journal
|
June 2020 |
|
Neuropilin-1 is a host factor for SARS-CoV-2 infection
|
journal
|
November 2020 |
|
Membrane Protein of Human Coronavirus NL63 Is Responsible for Interaction with the Adhesion Receptor
|
journal
|
October 2019 |
|
Two Mutations Were Critical for Bat-to-Human Transmission of Middle East Respiratory Syndrome Coronavirus
|
journal
|
June 2015 |
|
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV
|
journal
|
January 2021 |
|
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives
|
journal
|
January 2021 |
|
The Viral Spike Protein Is Not Involved in the Polarized Sorting of Coronaviruses in Epithelial Cells
|
journal
|
January 1998 |
|
Role of N-Linked Glycosylation of the Hendra Virus Fusion Protein
|
journal
|
May 2005 |
|
N-Glycans on Nipah Virus Fusion Protein Protect against Neutralization but Reduce Membrane Fusion and Viral Entry
|
journal
|
April 2006 |
|
Role of N-Linked Glycosylation of the Hendra Virus Fusion Protein
|
journal
|
May 2005 |
|
N-Glycans on Nipah Virus Fusion Protein Protect against Neutralization but Reduce Membrane Fusion and Viral Entry
|
journal
|
April 2006 |
|
Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit
|
journal
|
April 2019 |
|
Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?
|
journal
|
May 2020 |
|
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
|
journal
|
September 2000 |
|
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
|
journal
|
September 2000 |
|
The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET
|
journal
|
October 2020 |
|
Membrane binding proteins of coronaviruses
|
journal
|
April 2019 |
|
The Role of Collectins and Galectins in Lung Innate Immune Defense
|
journal
|
September 2018 |
|
C-Type Lectin-Like Receptors: Head or Tail in Cell Death Immunity
|
journal
|
February 2020 |
|
Human Sialome and Coronavirus Disease-2019 (COVID-19) Pandemic: An Understated Correlation?
|
journal
|
June 2020 |
|
Integrative View of the Diversity and Evolution of SWEET and SemiSWEET Sugar Transporters
|
journal
|
December 2017 |
|
Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2?
|
journal
|
February 2021 |
|
Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects
|
journal
|
August 2020 |
|
Glycosylation of Zika Virus is Important in Host–Virus Interaction and Pathogenic Potential
|
journal
|
October 2019 |
|
Sialic Acid Receptors: The Key to Solving the Enigma of Zoonotic Virus Spillover
|
journal
|
February 2021 |
|
The Hepatitis C Virus Glycan Shield and Evasion of the Humoral Immune Response
|
journal
|
October 2011 |
|
Playing Hide and Seek: How Glycosylation of the Influenza Virus Hemagglutinin Can Modulate the Immune Response to Infection
|
journal
|
March 2014 |
|
Toward Animal Cell Culture–Based Influenza Vaccine Design: Viral Hemagglutinin N-Glycosylation Markedly Impacts Immunogenicity
|
journal
|
January 2013 |
|
COVID ‐19 acute respiratory distress syndrome ( ARDS ): clinical features and differences from typical pre‐ COVID ‐19 ARDS
|
journal
|
June 2020 |
|
Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration
|
journal
|
October 2020 |